Press Release

PanOxyl® BPO Acne Treatment Bar Wins Coveted Allure Best of Beauty Award

Dermatologist-Recommended Brand Recognized for Innovation in Acne Care

September 16, 2025

NASHVILLE, Tenn., September 16, 2025 /PRNewswire/ -- Crown Laboratories, Inc., a Revance company, is proud to announce that its therapeutic skincare brand, PanOxyl®, has been awarded the prestigious 2025 Allure Best of Beauty Award for its Acne Treatment Bar 10% Benzoyl Peroxide. This marks the first time the product has received this honor, underscoring its efficacy and innovative format within the acne care category.

For more than 25 years, the Allure Best of Beauty Awards have set the gold standard in the industry, spotlighting products that deliver on their promises through rigorous testing and expert evaluation. PanOxyl’s dermatologist-backed Acne Treatment Bar stood out for its potent formula and convenient solid-bar format, designed to effectively treat acne on the face, chest, and back.

“Receiving an Allure Best of Beauty Award is one of the highest accolades in beauty,” said Nicole Watson, Senior Vice President, Therapeutics Marketing. “We’re honored to see the Acne Treatment Bar recognized this year for its ability to deliver real results and help people feel more confident in their skin.”

Formulated with 10% benzoyl peroxide, the maximum strength available without a prescription, PanOxyl’s Acne Treatment Bar works to eliminate acne-causing bacteria, clear blackheads, whiteheads, and pimples, and help prevent new breakouts. The formula is vegan, soap-free, pH-balanced, and free of added fragrances or dyes, making it suitable for acne-prone skin. Its solid-bar format offers a convenient, multi-purpose solution, perfect for at home or on the go.

The PanOxyl BPO Acne Treatment Bar is available nationwide at major retailers and online. For more information, please visit www.PanOxyl.com.

 

About PanOxyl®

Known for its #1 selling dermatologist-recommended acne products in the U.S., PanOxyl offers a full line of acne-prone skin care products designed to cleanse, manage, and moisturize to reveal your best-looking skin. Always backed by science, PanOxyl has been used and trusted by millions around the world for the last 50 years. For more information about PanOxyl or its products, visit www.panoxyl.com.

 

 

About Revance

Revance is a fast-growing, highly acquisitive, global aesthetics and skincare company committed to delivering innovative aesthetics and market-leading skincare solutions across every stage of life. With a differentiated portfolio and market position, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and the commercialization of new products and treatments. Focused on skin science for life, Revance continues to expand its global footprint, with distribution spanning 60 countries and a significant opportunity to enter new markets.

Revance’s balanced portfolio includes innovative products in the aesthetics space such as DAXXIFY® (DaxibotulinumtoxinA-lanm) for injection, the RHA® Collection of dermal fillers by Teoxane SA, and SkinPen®, an industry-leading microneedling device. RHA® technology is proprietary to and manufactured in Switzerland by Teoxane SA, and Revance is an independent distributor of Teoxane SA to supply the RHA Collection of dermal fillers to the U.S. market. In addition, its consumer skincare portfolio includes leading brands such as PanOxyl®, Blue Lizard®, StriVectin® and BIOJUVE®.

RHA® is a trademark of TEOXANE SA.

Learn more at Revance.com, RevanceAesthetics.com, CrownLaboratories.com, and CrownAesthetics.com. Please see DAXXIFY® full Prescribing Information, including Boxed Warning and Medication Guide.